Eli Lilly

Page 7 of 7

Eli Lilly & Co Chief Executive Officer John Lechleiter Interview
Health

Eli Lilly’s CEO John Lechleiter Is Retiring at the End of the Year

By
July 27, 2016
Johns Hopkins Hospital Continues Cancer Research And Treatment
Health

These Are the Most Promising Experimental Cancer Drugs

By
June 9, 2016
General Views of Eli Lilly & Co.
Health

Pharma Giant Eli Lilly Wants to Launch 20 New Drugs by 2023

By
May 24, 2016
The CEO of Valeant Pharmaceuticals has suggested that Allergan is fat, overstaffed and ripe for big
Health

Allergan Struck a $3.3 Billion Alzheimer’s Drug Deal Right After Its Pfizer Merger Collapsed

By
April 7, 2016
U.S. Multinationals in Puerto Rico
Health

Eli Lilly Just Lost the Latest Round in its Patent Battle

By
February 12, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
Finance

Biotech Stocks Crashed and Nobody Knows Why

By
January 29, 2016
U.S. Multinationals in Puerto Rico
Finance

Eli Lilly’s Outlook for 2016 Disappoints

By
January 5, 2016
CHINA-ECONOMY-STOCKS
Retail

China Stocks and December Auto Sales–5 Things to Know Today

By
January 5, 2016
Prediction: A New Drug Will Soon Offer Hope in the Alzheimer’s Fight
Health

Prediction: A New Drug Will Soon Offer Hope in the Alzheimer’s Fight

By
December 1, 2015
U.S. Multinationals in Puerto Rico
Health

FDA Approves New Eli Lilly Drug for Advanced Lung Cancer

By
November 24, 2015
Eli Lilly & Co's Zyprexa schizophrenia drug is pictured in a
Finance

Eli Lilly adds one more to roster of failed heart drugs, and it won’t be the last

By
October 12, 2015
General Views of Eli Lilly & Co.
Health

Why drug maker Eli Lilly’s stock price is down big today

By
October 12, 2015
Apple Worldwide Developers Conference Opens In San Francisco
Features

Apple, Greek banks, and earnings — 5 things to know this week

By
July 19, 2015

Most Popular